Published • loading... • Updated
US Medicare Pricing Policies Could Drive Global Costs And Hinder Access Worldwide
Summary by Health Policy Watch
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
US Medicare Pricing Policies Could Drive Global Costs And Hinder Access Worldwide
A new modelling study suggests that US Medicare “Most-Favored-Nation” policies on drug prices would cut Medicare spending on brand name drugs, but potentially incentivize companies to increase prices or delay new drug launches elsewhere. Efforts to control the cost of government spending on drugs culminated in a “Most-Favored-Nation” (MFN) policy–a Trump administration initiative which ties […]
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
